Viewing Study NCT07115004

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 8:03 PM
Ignite Modification Date: 2026-01-31 @ 10:21 AM
Study NCT ID: NCT07115004
Status: RECRUITING
Last Update Posted: 2025-12-04
First Post: 2025-08-04
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Study to Evaluate Subcutaneous (SC) VGA039 in Patients With Von Willebrand Disease (VWD)
Sponsor: Vega Therapeutics, Inc
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Von Willebrand Disease (VWD) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None VWD View
None von Willebrand Disease View
None VIVID-6 View
None Vega Therapeutics View
None Star Therapeutics View
None VGA039 View